Summary of Key Information:

Reporting Period (Quarter/Year): Quarter ended June 30, 2026 (Q1 FY27)

Nature of Filing / Announcement: Outcome of Board Meeting and Unaudited Financial Results with Limited Review Report

Audit Opinion:

Unmodified conclusion from statutory auditors (CNK & Associates LLP) on the limited review of the unaudited financial results.

Auditor’s Comment:

Emphasis of Matter regarding IPO-related expenditure of ₹31.86 million (including ₹2.64 million incurred during the quarter under review) included under Other Current Assets, proposed to be charged to Securities Premium account once the IPO process is completed.

Key Financial Highlights [Rs. In Millions]:

Standalone Results:

Revenue from Operations: ₹4,336.46 for Q1 FY27 (36% increase from ₹3,195.60 in Q1 FY26)

Total Income: ₹4,353.57 for Q1 FY27 (36% increase from ₹3,204.36 in Q1 FY26)

Net Profit: ₹610.23 for Q1 FY27 (151% increase from ₹243.38 in Q1 FY26)

EPS: ₹10.52 (Basic and Diluted) for Q1 FY27 (150% increase from ₹4.20 in Q1 FY26)

Quarterly Comparison:

| Particulars | Q1 FY27 (Jun 30, 2026) | Q4 FY26 (Mar 31, 2026) | Q1 FY26 (Jun 30, 2025) | FY26 (Mar 31, 2026) |

| Revenue from Operations | 4,336.46 | 3,349.12 | 3,195.60 | 12,325.93 |

| Total Income | 4,353.57 | 3,371.83 | 3,204.36 | 12,378.45 |

| Net Profit | 610.23 | 198.60 | 243.38 | 831.24 |

| EPS (₹) | 10.52 | 3.42 | 4.20 | 14.33 |

Expense Breakdown Q1 FY27:

Costs of materials consumed: ₹2,205.41

Purchases of stock-in-trade: ₹877.63

Changes in inventories: (₹391.99)

Employee benefits expense: ₹132.92

Finance costs: ₹18.21

Depreciation and amortisation expense: ₹66.11

Other expenses: ₹609.70

Other Financial Data:

Paid up share Capital: ₹116.00 million (Face value of ₹2 each)

Reserves excluding revaluation reserve: ₹4,369.05 million (as of Mar 31, 2026)

Segment-wise Performance:

The Company has only one primary reportable segment, which is Speciality Chemicals. Accordingly, no separate disclosures of segment information have been made.

Corporate Actions:

Not Specified

Other Significant Information:

  • The Company completed its Initial Public Offer (IPO) of 7,396,437 equity shares of face value of ₹2 each at an issue price of ₹676 per share, aggregating to ₹5,000 million.
  • The IPO comprised an offer for sale of 6,213,006 equity shares by selling shareholders aggregating to ₹4,200 million and fresh issue of 1,183,431 equity shares aggregating to ₹800 million.
  • Equity shares were listed on NSE and BSE on September 16, 2026.
  • These unaudited financial results for Q1 FY27 have been drawn up for the first time in accordance with the Listing Regulations following the IPO.
  • The financial results for Q4 FY26 (Mar 31, 2026) were approved by the Board but have not been subject to limited review or audit.
  • The financial results for Q1 FY25 (Jun 30, 2025) were audited for inclusion in IPO offer documents.